Nitric oxide (NO) and somatostatin (SS) are two important mediators of the
exocrine and endocrine pancreas, exerting opposite effects on this organ. T
here is strong evidence suggesting an interaction between pancreatic NO and
SS. The aim of this study was to determine whether L-arginine (L-Arg), the
substrate for NO synthase (NOS), and N-omega-nitro-L-arginine methyl ester
(L-NAME), a NOS inhibitor, regulate pancreatic somatostatin-like immunorea
ctivity (SSLI) content and the SS mechanism of action in pancreatic acinar
cell membranes. L-Arg (150 mg/kg, intraperitoneally (i.p.)), L-NAME (50 mg/
kg, i.p.) or L-NAME plus L-Arg were injected twice daily at 8 h intervals f
or 8 days. L-Arg decreased pancreatic SSLI content as well as the number of
SS receptors in pancreatic acinar cell membranes whereas L-NAME increased
both parameters. The stable SS analogue SMS 201-995 induced a significantly
lower inhibition of forskolin-stimulated adenylyl cyclase activity in panc
reatic acinar cell membranes from L-Arg-treated rats whereas an increased i
nhibition was observed in pancreatic acinar membranes from L-NAME-treated r
ats. These results indicate that the NO system may contribute to the regula
tion of the pancreatic somatostatinergic system. (C) 1999 Elsevier Science
B.V. All rights reserved.